Amlodipine Besylate/Atorvastatin Calcium Hydrate/Perindopril Arginine

苯磺酸氨氯地平/阿托伐他汀钙水合物/精氨酸培哚普利

Report date: 2022/03/08 16:45:37

Base Information

Drug NameAmlodipine Besylate/Atorvastatin Calcium Hydrate/Perindopril Arginine
Drug Alias NameAmlodipine/atorvastatin/perindoprilTriveramLipertanceStatriamS-05153
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersAngiotensin-converting enzyme inhibitorsHMG-CoA reductase inhibitors
TargetsVoltage-gated calcium channelAngiotensin-converting enzymeHMG-CoA reductase
Therapy Area/IndicationsDyslipidemiasHypertension
Global Approved IndicationsDyslipidemiasHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryBulgaria
Original Approved Date2015/10/23
Country/TerritoryBulgaria
CombinationsYes Amlodipine BesylateAtorvastatin Calcium HydratePerindopril Arginine
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLes Laboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesLes Laboratoires Servier
Inactive CompaniesN/A
Active IndicationsDyslipidemiasHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC10BX11
Related LinksN/A